Literature DB >> 34969593

"Which one should I choose, a glucagon-like peptide-1 receptor agonist or a sodium-glucose cotransporter 2 inhibitor? Or maybe both?"

Dimitrios Patoulias1, Christodoulos Papadopoulos2, Asterios Karagiannis3, Michael Doumas4.   

Abstract

Entities:  

Keywords:  Cardiovascular disease; GLP-1RA; SGLT-2 inhibitor

Mesh：

Substances：

Year:  2021        PMID： 34969593     DOI： 10.1016/j.ejim.2021.12.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  1 in total

1.  SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?

Authors:  Dimitrios Patoulias; Theodoros Michailidis
Journal:  J Clin Transl Hepatol       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.